Status:
COMPLETED
Study Of Adults And Adolescents With Vasomotor Rhinitis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Vasomotor
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Must be outpatients.
- Diagnosis of VMR.
- Literate in English or native language.
- Exclusion criteria:
- Significant concomitant medical condition.
- Use corticosteroids or other allergy medications during the study.
- Used tobacco products within the past year.
Exclusion
Key Trial Info
Start Date :
July 11 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2006
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT00117325
Start Date
July 11 2005
End Date
February 9 2006
Last Update
March 13 2018
Active Locations (53)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Beverly Hills, California, United States, 90212
2
GSK Investigational Site
Huntington Beach, California, United States, 92647
3
GSK Investigational Site
Mission Viejo, California, United States, 92691
4
GSK Investigational Site
San Diego, California, United States, 92120